401 related articles for article (PubMed ID: 26404943)
1. Usefulness of N-Terminal Pro-Brain Natriuretic Peptide to Predict Mortality in Adults With Congenital Heart Disease.
Popelová JR; Kotaška K; Tomková M; Tomek J
Am J Cardiol; 2015 Nov; 116(9):1425-30. PubMed ID: 26404943
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.
Zhu Q; Xiao W; Bai Y; Ye P; Luo L; Gao P; Wu H; Bai J
Clin Interv Aging; 2016; 11():245-53. PubMed ID: 27013868
[TBL] [Abstract][Full Text] [Related]
3. Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years.
Eggers KM; Venge P; Lind L
Am J Cardiol; 2013 Jan; 111(1):131-6. PubMed ID: 23040598
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
[TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
[TBL] [Abstract][Full Text] [Related]
6. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.
Schouten O; Hoeks SE; Goei D; Bax JJ; Verhagen HJ; Poldermans D
J Vasc Surg; 2009 Feb; 49(2):435-41; discussion 441-2. PubMed ID: 19028043
[TBL] [Abstract][Full Text] [Related]
7. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
[TBL] [Abstract][Full Text] [Related]
8. Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old.
Poortvliet R; de Craen A; Gussekloo J; de Ruijter W
Age Ageing; 2015 Sep; 44(5):841-7. PubMed ID: 26209786
[TBL] [Abstract][Full Text] [Related]
9. N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease.
Ndrepepa G; Kastrati A; Braun S; Mehilli J; Niemöller K; von Beckerath N; von Beckerath O; Vogt W; Schömig A
Am J Med; 2006 Apr; 119(4):355.e1-8. PubMed ID: 16564781
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Serial N-Terminal Pro-B-Type Natriuretic Peptide Measurements in Adults With Congenital Heart Disease.
Baggen VJM; Baart SJ; van den Bosch AE; Eindhoven JA; Witsenburg M; Cuypers JAAE; Roos-Hesselink JW; Boersma E
J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29581225
[TBL] [Abstract][Full Text] [Related]
11. Prospective monitoring N-terminal pro-brain natriuretic peptide during natural progression of atherosclerotic renal artery stenosis in elderly.
Zhu Q; An N; Bai Y; Zhu N; Li M
Arch Gerontol Geriatr; 2013; 56(2):395-9. PubMed ID: 23153984
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of N-Terminal Pro-B-Type Natriuretic Peptide in Takotsubo syndrome.
Stiermaier T; Santoro F; Graf T; Guastafierro F; Tarantino N; De Gennaro L; Caldarola P; Di Biase M; Thiele H; Brunetti ND; Möller C; Eitel I
Clin Res Cardiol; 2018 Jul; 107(7):597-606. PubMed ID: 29675571
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of Serial N-terminal Pro-B-type Natriuretic Peptide Measurements to Predict Cardiac Death in Acute and Chronic Dilated Cardiomyopathy in Children.
den Boer SL; Rizopoulos D; du Marchie Sarvaas GJ; Backx AP; Ten Harkel AD; van Iperen GG; Rammeloo LA; Tanke RB; Boersma E; Helbing WA; Dalinghaus M
Am J Cardiol; 2016 Dec; 118(11):1723-1729. PubMed ID: 27692597
[TBL] [Abstract][Full Text] [Related]
14. Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure.
Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
J Card Fail; 2013 Jan; 19(1):31-9. PubMed ID: 23273592
[TBL] [Abstract][Full Text] [Related]
15. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
16. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide predict mortality in stable coronary artery disease: results from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
Giannitsis E; Spanuth E; Horsch A; Kleber ME; Koch W; Grammer TB; Koenig W; März W
Clin Chem Lab Med; 2013 Oct; 51(10):2019-28. PubMed ID: 24072576
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease.
Baggen VJ; van den Bosch AE; Eindhoven JA; Schut AW; Cuypers JA; Witsenburg M; de Waart M; van Schaik RH; Zijlstra F; Boersma E; Roos-Hesselink JW
Circulation; 2017 Jan; 135(3):264-279. PubMed ID: 27832613
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with chronic aortic regurgitation.
Weber M; Hausen M; Arnold R; Moellmann H; Nef H; Elsaesser A; Mitrovic V; Hamm C
Int J Cardiol; 2008 Jul; 127(3):321-7. PubMed ID: 18055041
[TBL] [Abstract][Full Text] [Related]
19. Determination of a predictive cutoff value of NT-proBNP testing for long-term survival in ED patients with acute heart failure.
Velibey Y; Golcuk Y; Golcuk B; Oray D; Atilla OD; Colak A; Kurtulmus Y; Erbay AR; Yilmaz A; Eren M
Am J Emerg Med; 2013 Dec; 31(12):1634-7. PubMed ID: 24055249
[TBL] [Abstract][Full Text] [Related]
20. Clinical and prognostic implications of plasma NGAL and NT-proBNP in adult patients with congenital heart disease.
Frogoudaki A; Andreou C; Parissis J; Maniotis C; Nikolaou M; Rizos I; Filippatos G; Lekakis J
Int J Cardiol; 2014 Dec; 177(3):1026-30. PubMed ID: 25449518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]